arXiv paper· computational biology / NLP for science· benchmark

HypoKG: Evidence-Disciplined Biomedical Hypothesis Generation Beyond Endpoint Knowledge

Dominic Okonkwo, Adetayo Okunoye, Ismailcem Budak Arpinar

cs.CL · cs.AI · q-bio.QM

Quick verdict

Claims full KG paths discipline LLM hypotheses beyond endpoint knowledge; strong controls, but the key metric embeds the claim and no code release.

Summary

The paper introduces HypoKG, a benchmark testing whether multi-hop knowledge-graph paths discipline LLM-generated biomedical hypotheses beyond simply revealing a source-disease pair. The authors integrate KEGG, Rhea, and UniProt into a 17,449-node, 31,709-edge biochemical graph, sample 550 enzyme-to-rare-disease paths (94.5% without PubMed co-citation), and elicit 13,200 hypotheses from six LLMs under four conditions: source-only (C1), full-path compression (C2), full-path interpretation (C3), and endpoint-only (C4). A five-criterion rubric is applied by two LLM judges (Pearson r=0.776 agreement), plus blinded human expert scoring on 55 paths. Endpoint-only prompting achieves the highest total score (16.68 vs 15.14/14.96 for C2/C3), but path conditions significantly raise evidence proportionality (C2 vs C4: +0.23, p<0.001, d=0.256). A shuffled-path control holding endpoints fixed drops evidence proportionality by 0.793 (C2, p<0.001) without changing novelty, supporting genuine path use by larger and domain-specialized models; BioMistral-7B shows no path sensitivity. Experts confirmed the C2>C3>C4>C1 ordering with a 90.3% path-grounded win rate. Limitations: the evidence-proportionality metric structurally favors path-seeing generators (C4 bridges capped at 3) and has the lowest judge agreement (r=0.668); human validation covers only this one criterion on 55 paths; no code or data release is stated; KG integration and hub-node handling (60% of paths via annotation hubs) are thinly documented.

Review complete

Assessment at a glance

computational biology / NLP for science

6

risk flags identified

● high 1

● medium 3

● low 2

Reproducibility readinessmedium
Code & data availablenot stated
Review confidencehigh
AI text signal0/20 passages flagged
Deep research viable

5 strengths · 5 weaknesses · 5 author questions

AI text signal = Binoculars zero-shot detector score over 20 sampled passages (Fast-DetectGPT co-reported) — absence does not prove human authorship, and a flag does not imply misconduct.

Levels reflect verification complexity — not a quality score. Evolve never rates your paper.

Key claims under review

  • Endpoint-only prompting (C4) achieves the highest total rubric score (16.68) but full KG paths specifically improve evidence proportionality (C2 vs C4: +0.23, p<0.001, d=0.256).
  • Shuffling intermediate path nodes while holding endpoints fixed drops evidence proportionality by 0.793 (C2, p<0.001) without changing novelty, providing causal evidence that models genuinely use ordered path structure.
  • Path utilization is model-dependent: stronger and domain-specialized models show C3−C1 gains of 3.1–4.2 points, while BioMistral-7B shows near-zero gains and no shuffle sensitivity.
  • Three blinded PhD experts confirm the condition ordering C2>C3>C4>C1 on 55 paths with a 90.3% path-grounded win rate and flag 90.9% of C4 outputs as speculative.
  • Very long paths dilute grounding benefit (C3−C1 gain correlates r=−0.223 with crossing count), so path complexity should be treated as a benchmark design variable.

Strengths

  • Endpoint-only ablation cleanly isolates the research question

    C4 (source+disease only, §3.5) tests whether full KG paths add value beyond revealing the pair, and the authors correctly note the C4 pair was itself KG-discovered — so the comparison does not strawman ungrounded generation. They claim it is the first such ablation for KG-grounded hypothesis generation.

  • Shuffled-path control provides causal evidence, not just correlation

    Holding endpoints fixed while permuting intermediates drops evidence proportionality by 0.793 for C2 (2.805→2.012, p<0.001, N=2,590) with novelty unchanged (p=0.215), and prompts held constant (§4.5, Table 6). The model-dependent pattern (Qwen3-235B −1.110 vs BioMistral-7B −0.023 ns) is internally coherent with Table 3.

  • Blinded human validation with within-path design

  • Candid reporting of inconvenient results

  • Disease-drift is quantified, not just narrated

Weaknesses

  • The central metric partially encodes the paper's conclusion

  • Lowest measurement reliability exactly where the claim lives

  • Prompt-framing confound never fully ablated

  • Human validation is narrow relative to the claims

  • No artifact release for a benchmark paper

Full Review Report

$1.99 · one-time

Unlock the complete preliminary analysis Evolve produced for this paper.

Report preview

Scope & Claims

HypoKG (arXiv 2609.12260) asks whether multi-hop knowledge-graph paths change LLM biomedical hypothesis generation beyond simply revealing a source enzyme-disease endpoint pair. The authors build an integrated human-only KEGG-Rhea-UniProt graph (17,449 nodes, 31,709 edges), sample 550 enzyme-to-rare-disease paths (417 sources, 366 endpoints; 94.5% with zero PubMed co-citation), and generate 13,200 hypotheses from six LLMs under four conditions: C1 source-only, C2 full-path compression, C3 full-path interpretation, C4 endpoint-only. Central claims: (1) C4 wins total rubric score (16.68 vs 15.14/14.96) but full paths specifically raise evidence proportionality (C2 vs C4 +0.23, p<0.001, d=0.256); (2) a shuffled-path control (Δ=−0.793 for C2, novelty unchanged) proves genuine path-structure use — 'evidence-disciplined reasoning'; (3) the effect is model-dependent; (4) blinded experts confirm the ordering.

The remaining sections cover Methodology Assessment, Statistical Evidence, Results & Reproducibility, Limitations & Risks, and Verdict & Recommendations.

  • All 5 strengths & 5 weaknesses, analyzed in detail
  • 6 risk flags with severity, section & reviewer questions
  • Methods & statistical evidence assessment
  • 5 questions a peer reviewer would ask
  • Full six-dimension evaluation report & recommendations

One-time purchase · this paper only

One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.

Frequently asked questions

What is the main finding of the HypoKG paper?

That giving LLMs the full knowledge-graph path between an enzyme and a rare disease does not produce the highest-scoring hypotheses — endpoint-only prompting does (total score 16.68 vs 15.14/14.96) — but full paths significantly improve 'evidence proportionality', i.e., whether the mechanistic claim matches the evidence provided. A shuffle control (that criterion drops by 0.793 when intermediate nodes are permuted with endpoints fixed, p<0.001) shows models genuinely use the path structure.

Which models actually used the knowledge-graph paths in HypoKG?

Larger and domain-specialized models — Qwen3-235B, Claude Sonnet 4.6, MedGemma-27B, GPT-4o — showed large evidence-proportionality drops under shuffled paths (0.68–1.11), indicating real path use. BioMistral-7B showed a non-significant C3 drop (−0.023, p=0.242), meaning it ignored path structure, and Llama-3.3-70B had near-zero grounding gains (C3−C1 +0.62).

How were the 13,200 hypotheses evaluated in HypoKG?

A five-criterion rubric (path relevance, mechanistic specificity, experimental testability, novelty, evidence proportionality; 1–5 each, total 5–25) was applied by two LLM judges — GPT-4o as primary (except for GPT-4o's own outputs, judged by Qwen3-235B) and Gemini 2.5 Flash as secondary. Primary-secondary agreement was Pearson r=0.776 overall and lowest, 0.668, on evidence proportionality. Three blinded PhD experts also scored 55 paths.

Is the HypoKG benchmark or its code publicly available?

The paper describes the construction in detail (integrated KEGG–Rhea–UniProt graph of 17,449 nodes; 550 paths; full prompts in Appendix A), but the provided text contains no code or data availability statement, so public availability currently appears limited and replication depends on the authors releasing artifacts.

About this review

This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.

  • Figures 1–2 are extracted as flattened inline text, so visual elements (e.g., error bars, bar scaling) could not be inspected; all cited numeric values are from tables and body text, which extracted completely.

Go deeper on this paper

Reproduce ResultsNot feasible for this paper — the core results cannot be re-derived by sandboxed code simulation.

Wrote a paper? Stress-test it before reviewers do.

Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.

Scan your paper
HypoKG: Evidence-Disciplined Biomedical Hypothesis Generation Beyond Endpoint Knowledge | Evolve.Pub